- Home
- CMBM vs LVTX Comparison
CMBM vs LVTX Comparison
Compare CMBM & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- LVTX
- Stock Information
- Founded
- CMBM 2011
- LVTX 2016
- Country
- CMBM United States
- LVTX Netherlands
- Employees
- CMBM N/A
- LVTX N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- LVTX Health Care
- Exchange
- CMBM Nasdaq
- LVTX Nasdaq
- Market Cap
- CMBM 50.8M
- LVTX 43.7M
- IPO Year
- CMBM 2019
- LVTX 2021
- Fundamental
- Price
- CMBM $1.16
- LVTX $1.57
- Analyst Decision
- CMBM Strong Buy
- LVTX Strong Buy
- Analyst Count
- CMBM 3
- LVTX 2
- Target Price
- CMBM $5.50
- LVTX $6.00
- AVG Volume (30 Days)
- CMBM 91.4K
- LVTX 71.0K
- Earning Date
- CMBM 11-07-2024
- LVTX 11-22-2024
- Dividend Yield
- CMBM N/A
- LVTX N/A
- EPS Growth
- CMBM N/A
- LVTX N/A
- EPS
- CMBM N/A
- LVTX N/A
- Revenue
- CMBM $172,215,000.00
- LVTX $7,398,000.00
- Revenue This Year
- CMBM N/A
- LVTX N/A
- Revenue Next Year
- CMBM $18.55
- LVTX N/A
- P/E Ratio
- CMBM N/A
- LVTX N/A
- Revenue Growth
- CMBM N/A
- LVTX N/A
- 52 Week Low
- CMBM $1.08
- LVTX $1.35
- 52 Week High
- CMBM $6.50
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- CMBM 38.76
- LVTX 37.66
- Support Level
- CMBM $1.12
- LVTX $1.75
- Resistance Level
- CMBM $1.29
- LVTX $1.86
- Average True Range (ATR)
- CMBM 0.10
- LVTX 0.13
- MACD
- CMBM 0.00
- LVTX -0.04
- Stochastic Oscillator
- CMBM 10.53
- LVTX 4.35
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.